Skip to main content

Are you a legal professional? Visit our professional site

Search for legal issues
For help near (city, ZIP code or county)
Please enter a legal issue and/or a location

Janssen Pharm. N.V. v. Teva Pharm. USA, Inc., No. 08-1594

Article Placeholder Image
By FindLaw Staff on September 25, 2009 3:27 PM

In a patent case involving a method for treating Alzheimer's disease and related dementias, district court's conclusion that the claims of the patent '318 were invalid is affirmed as the patent's description of using galantamine to treat the disease does not satisfy the enablement requirement because the patent application did not establish utility.     

Read Janssen Pharm. N.V. v. Teva Pharm. USA, Inc., No. 08-1594

Appellate Information

Appeal from:  United States District Court for the District of New Jersey

Decided September 25, 2009


Before Mayer, Gajarsa, and Dyk, Circuit Judges

Opinion by Dyk, Circuit Judge.   


For Appellant:  George F. Pappas, Covington & Burling LLP

For Appellee:  William A. Rakoczy, Rakoczy Molino Mazzochi Siwik LLP; George C. Lombardi, Winston & Strawn LLP

Find a Lawyer

More Options